Xtant Medical Completes Acquisition Of Surgalign’S Hardware And Biologics Business
Acquiring Company
Xtant Medical Holdings
Acquired Company
Biologics
New YorkManufacturingBiotechnologyHealth CareMedicalMedical DeviceBiotechnologyHealth CareDescription
Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it completed the acquisition of certain assets and liabilities related to the domestic and international biologics and spinal fixation offerings of Surgalign Holdings, Inc. under a Bankruptcy Court supervised process for $5 million, plus assumed liabilities, in an all-cash transaction.
Quick answer
Xtant Medical Holdings is acquiring Biologics and Surgalign, announced August 10, 2023.
- How much did Xtant Medical Holdings pay for Biologics?
- The deal value was not disclosed.
- What does Xtant Medical Holdings do?
- Xtant Medical (NYSE MKT: XTNT) develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets.
- Where are Xtant Medical Holdings and Biologics based?
- Biologics is based in New York, United States.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Medical Device
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Theken Companies Acquires Visionair Solutions (August 22, 2023)
- Caldera Medical Acquires Atlantic Therapeutics To Expand Portfolio In Women’S Health (September 6, 2023)
- Abbott Completes Acquisition Of Bigfoot Biomedical (September 22, 2023)
- Abbott To Acquire Bigfoot Biomedical, Furthering Efforts To Develop Personalized, Connected Solutions For People With Diabetes (September 5, 2023)
- Radon Medical Imaging Announces Acquisition Of Tristate Biomedical Solutions (July 11, 2023)
- Biocoat Acquires Chempilots To Expand Its Biomaterial Platform (July 11, 2023)
Who to call at Xtant Medical Holdings, and when
When Xtant Medical Holdings changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Xtant Medical Holdings raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Xtant Medical Holdings, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Xtant Medical Holdings. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Xtant Medical Holdings makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Biologics?
Biologics was acquired by Xtant Medical Holdings. The deal was reported on August 10, 2023. Xtant Medical (NYSE MKT: XTNT) develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. Xtant Medical Holdings is publicly traded (XTNT) and operates in Manufacturing.
When did Xtant Medical Holdings acquire Biologics?
Xtant Medical Holdings's acquisition of Biologics was reported on August 10, 2023. Xtant Medical Holdings, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Biologics do?
It is privately held, operating in Biotechnology, and is based in New York.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.